OBJECTIVE: To investigate the extent of carotid atherosclerosis and the effect of weight loss on carotid intima-media thickness (IMT) in obese premenopausal women. RESEARCH METHODS AND PROCEDURES: In 43 obese premenopausal women who participated in a 3-month weight reduction program with a hypocaloric diet, IMT was measured by B-mode high-resolution ultrasound at entry and after 5 months of follow-up. Blood samples were analyzed at entry, after intervention, and after 5 months of follow-up. Nineteen lean women served as control subjects. RESULTS: At entry, common carotid IMT (0.72 vs. 0.59 mm), carotid bulb IMT (0.90 vs. 0.71 mm), and overall mean IMT (0.81 vs. 0.65 mm) were greater in obese women than in lean women (all p < 0.01). After dietary intervention decreases in blood pressure, low density lipoprotein to high density lipoprotein cholesterol ratio, triglycerides, fibrinogen, plasminogen activator inhibitor-1, and an increase in tissue-type plasminogen activator activity levels were observed. These effects persisted after follow-up in 14 women who maintained reduced weight. Reduction in carotid bulb IMT (to 0.81 mm, p < 0.01) and overall mean IMT (to 0.79 mm, p < 0.05) was observed in this subgroup. No significant change of carotid IMT was detected in eight women who regained weight. Changes in IMT were associated independently and significantly with changes in body mass index, low density lipoprotein to high density lipoprotein cholesterol ratio, and plasminogen activator inhibitor-1 antigen. DISCUSSION: Obese premenopausal women had greater IMT than did age-matched lean controls. It seems that this early atherosclerotic changes may be reversed by normalization of body weight.
OBJECTIVE: To investigate the extent of carotid atherosclerosis and the effect of weight loss on carotid intima-media thickness (IMT) in obese premenopausal women. RESEARCH METHODS AND PROCEDURES: In 43 obese premenopausal women who participated in a 3-month weight reduction program with a hypocaloric diet, IMT was measured by B-mode high-resolution ultrasound at entry and after 5 months of follow-up. Blood samples were analyzed at entry, after intervention, and after 5 months of follow-up. Nineteen lean women served as control subjects. RESULTS: At entry, common carotid IMT (0.72 vs. 0.59 mm), carotid bulb IMT (0.90 vs. 0.71 mm), and overall mean IMT (0.81 vs. 0.65 mm) were greater in obesewomen than in lean women (all p < 0.01). After dietary intervention decreases in blood pressure, low density lipoprotein to high density lipoprotein cholesterol ratio, triglycerides, fibrinogen, plasminogen activator inhibitor-1, and an increase in tissue-type plasminogen activator activity levels were observed. These effects persisted after follow-up in 14 women who maintained reduced weight. Reduction in carotid bulb IMT (to 0.81 mm, p < 0.01) and overall mean IMT (to 0.79 mm, p < 0.05) was observed in this subgroup. No significant change of carotid IMT was detected in eight women who regained weight. Changes in IMT were associated independently and significantly with changes in body mass index, low density lipoprotein to high density lipoprotein cholesterol ratio, and plasminogen activator inhibitor-1 antigen. DISCUSSION: Obese premenopausal women had greater IMT than did age-matched lean controls. It seems that this early atherosclerotic changes may be reversed by normalization of body weight.
Authors: Mohamed Hassan Saleh; Marcelo Chiara Bertolami; Jorge Eduardo Assef; Mohamed Ibrahim Taha; Wilson de Freitas; Ana Claudia Gomes Petisco; Rodrigo Bellio Mattos Barretto; David Costa Le Bihan; Jose Eduardo Martins Barbosa; Carlos Alberto de Jesus; Amanda Guerra Moraes Rego Sousa Journal: Obes Surg Date: 2012-11 Impact factor: 4.129
Authors: G Lambert; Marcelo Miranda de Oliveira Lima; A C Felici; J C Pareja; A C J Vasques; F S Novaes; S Rodovalho; F F P Hirsch; J R Matos-Souza; Élinton A Chaim; B Geloneze Journal: Obes Surg Date: 2018-01 Impact factor: 4.129
Authors: Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román Journal: Endocr Metab Immune Disord Drug Targets Date: 2010-06 Impact factor: 2.895
Authors: Jennifer N Cooper; Jeanine M Buchanich; Ada Youk; Maria Mori Brooks; Emma Barinas-Mitchell; Molly B Conroy; Kim Sutton-Tyrrell Journal: Atherosclerosis Date: 2012-05-30 Impact factor: 5.162
Authors: Lisa de las Fuentes; Alan D Waggoner; B Selma Mohammed; Richard I Stein; Bernard V Miller; Gary D Foster; Holly R Wyatt; Samuel Klein; Victor G Davila-Roman Journal: J Am Coll Cardiol Date: 2009-12-15 Impact factor: 24.094
Authors: Janet Lo; Sara E Dolan; Jenna R Kanter; Linda C Hemphill; Jean M Connelly; Robert S Lees; Steven K Grinspoon Journal: J Clin Endocrinol Metab Date: 2006-03-07 Impact factor: 5.958
Authors: Jennifer N Cooper; Mindy L Columbus; Kelly J Shields; Julius Asubonteng; Michelle L Meyer; Kim Sutton-Tyrrell; Bret H Goodpaster; James P DeLany; John M Jakicic; Emma Barinas-Mitchell Journal: Metabolism Date: 2012-05-09 Impact factor: 8.694
Authors: Colin Wilborn; Jacqueline Beckham; Bill Campbell; Travis Harvey; Melyn Galbreath; Paul La Bounty; Erika Nassar; Jennifer Wismann; Richard Kreider Journal: J Int Soc Sports Nutr Date: 2005-12-09 Impact factor: 5.150